Clearside Biomedical's Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® in Uveitic Macular Edema Patients.
Biopharmaceutical Company Reports Positive Topline Results From Uveitic Macular Edema Clinical Trial
Biopharmaceutical Company Reports Positive…
Biopharmaceutical Company Reports Positive Topline Results From Uveitic Macular Edema Clinical Trial
Clearside Biomedical's Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® in Uveitic Macular Edema Patients.